GPF is an Editorial Board member of Diabetes Therapy
Phil Browne Nov 29, 2025 4 min read If youve started (or are considering) Semaglutide for weight loss, youve probably heard that one of its biggest advantages is how effectively it quiets hunger
Their use should be limited to clear medical indicationstype 2 diabetes, obesity, insulin resistance, or elevated cardiometabolic riskand always integrated into a care plan that considers a womans reproductive goals, hormonal therapies, and individual symptom profile
Hi there
We believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach, ensuring that your treatment plan is tailored to your unique needs and delivered safely
We interpret the clinical and mechanistic data obtained for different agents that enable weight loss and glucose control for the treatment of obesity and type 2 diabetes mellitus, respectively, by activating or blocking GIPR signalling, including the GIPRGLP1R co-agonist tirzepatide, as well as the GIPR antagonistGLP1R agonist AMG-133